Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Other Non Operating Income (2019)

SELLAS Life Sciences (SLS) has disclosed Other Non Operating Income for 4 consecutive years, with $6.8 million as the latest value for Q4 2019.

  • Quarterly Other Non Operating Income changed N/A to $6.8 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $668000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $208000.0 for FY2020, 68.86% down from the prior year.
  • Other Non Operating Income for Q4 2019 was $6.8 million at SELLAS Life Sciences, up from -$5.0 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $6.8 million in Q4 2019, with the low at $6.8 million in Q4 2019.